RD Saúde Adjusted Profit Rises 23% as Digital Sales Surge
GLP-1 demand and market-share gains lift revenue 18%, while free cash flow turns positive and leverage falls to 0.8 times EBITDA.
GLP-1 demand and market-share gains lift revenue 18%, while free cash flow turns positive and leverage falls to 0.8 times EBITDA.
A ruling against Drogasil questions whether retailers can make lower prices depend on customers handing over personal data.
Retail pharmacy giant posts strong revenue growth and market-share gains as GLP-1 drugs and omnichannel sales boost performance.
Company opens 88 new stores, hits R$12.1 billion in sales and R$402 million in profit amid strong e-commerce momentum.